Caribou Biosciences CRBU
NASDAQ CRBU
$1.22 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Caribou Biosciences (CRBU) Return on Assets [ROA] (2021 - 2026)

Updated

Caribou Biosciences' Return on Assets [ROA] was -75.04% in Q2 2026, down 7.26 percentage points from -67.78% a year earlier but up 6.17 percentage points from the prior quarter.

Analysis

Caribou Biosciences (CRBU) Return on Assets [ROA] (2021 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Caribou Biosciences came in at -60.62%, down 20.62 percentage points from FY2024.

  • Return on Assets [ROA] has now declined for three consecutive years, with a four-year change of -32.64 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Assets [ROA] was -40.00% in FY2024 (-14.67 pp), -25.33% in FY2023 (-0.96 pp), -24.36% in FY2022 (+3.61 pp) and -27.98% in FY2021.
  • Quarterly Return on Assets [ROA] has moved between -81.21% (Q1 2026) and -14.80% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Assets [ROA] has declined for nine straight quarters, with an average year-over-year change of -24.01 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2023 (a gain of 1.45 percentage points); the worst was Q2 2025 (a drop of 31.47 percentage points).
  • Per Business Quant data, CRBU's Return on Assets [ROA] in the three quarters before Q2 2026 was -81.21% (Q1 2026), -80.11% (Q4 2025) and -76.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Caribou Biosciences 129.31 Mn -387.22 Mn - -75.04%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -75.04%
Mar 31, 2026 -81.21%
Dec 31, 2025 -80.11%
Sep 30, 2025 -76.35%
Jun 30, 2025 -67.78%
Mar 31, 2025 -55.72%
Dec 31, 2024 -50.67%
Sep 30, 2024 -46.06%
Jun 30, 2024 -36.31%
Mar 31, 2024 -31.21%
Dec 31, 2023 -26.09%
Sep 30, 2023 -27.06%
Jun 30, 2023 -34.74%
Mar 31, 2023 -32.35%
Dec 31, 2022 -27.54%
Sep 30, 2022 -22.99%
Jun 30, 2022 -20.46%
Mar 31, 2022 -16.80%
Dec 31, 2021 -14.80%
Sep 30, 2021 -20.36%
API Access

Caribou Biosciences Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRBU&period=max&api_key=YOUR_API_KEY